Pretty much standard
Despite an auspicious first week, Standard Life (LON:SLA) Aberdeen shares continue to signal investors are less than assured about the newly combined company.
The stock gained as much as 2.8% last week, though closed on Friday up a more modest 1.8%. Standard Life (Aberdeen) has advanced some 16% since 2nd March, when Standard Life and Aberdeen Asset Management announced their intention to merge. That’s slightly more than the 13% rise by a Thomson Reuters index including leading active investment managers, of which SLA is now the largest. In other words, Standard Life Aberdeen’s efforts to fight off ‘passive’ competitors are widely expected to bear only modest fruit.
It’s worth noting that shares in the Aberdeen bit of the new co. rose around 30% between the start of the year and about a fortnight ago. That was to be expected. Its investors received the best half of the ‘merger’ deal as Aberdeen equity was diluted the most. But erstwhile Standard Life stock now represents the combined group, and that is up pretty much in line with peers.
SLA NPV
That reflects conservative merger synergies. SLA officially projected these would be around £200m a year within three years of completion, with an initial cost of £320m. On that basis, the merger returns a positive net present value, £75m—before tax—only after the fifth year. On a perpetuity basis, Thomson Reuters calculates net present value of savings as worth $1.3bn. SLA will of course keep facing ‘passive’ pressure before synergies kick in, another small red flag. For example, Standard Life's flagship £44bn Global Absolute Return Strategies fund saw £5.6bn net outflows in the first half, despite making a better than expected £362m operating profit. Such pressures will probably moderate, though it’s difficult to forecast when. Even after factoring them in, it looks like shareholders don’t believe £200m in savings each year will be sustainable.
Second-half slippage
Flows on the Aberdeen side have been just as precarious over the last few years. Its emerging markets exposure is a frequent source of volatility. SLA's joint-CEO structure is another niggle that may have capped its stock. These set ups sometimes work for global companies, but major investors don’t like them. There’s too much room for ego-fuelled disruption.
Of course, there’s scope for the new group to set new standards that eventually impress scepticism away. SLA’s below-peer group average forward rating also offers leeway. But short of a strongly accretive growth spurt, Standard Life Aberdeen’s shares are unlikely to be the dons of the sector by year end.
Disclaimer: The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient.
Any references to historical price movements or levels is informational based on our analysis and we do not represent or warrant that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, the author does not guarantee its accuracy or completeness, nor does the author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.